Tracking Developmental Milestones

Tracking Developmental Milestones

Applies ASQ-3, ASQ:SE-2, and CDC milestone checklists to systematically track gross motor, fine motor, language, cognitive, and social-emotional domains across well-child visits. Produces a developmental surveillance report with referral triggers for Early Intervention and subspecialty evaluation.

Why This Skill Exists

Developmental delays affect approximately 1 in 6 children, yet fewer than half are identified before school entry. AAP Bright Futures guidelines mandate structured developmental surveillance at every well-child visit and formal screening with validated tools at 9, 18, and 30 months. Autism-specific screening is required at 18 and 24 months. This skill ensures no screening window is missed and referral criteria are applied consistently.

Checkpoint A — Intake Verification

Required Intake Questions

1. What is the child's corrected age (if born preterm < 37 weeks, correct until age 2)?
2. What is the visit type (well-child, developmental concern follow-up, Early Intervention referral)?
3. What developmental concerns, if any, has the parent/caregiver raised?
4. Is there a history of prematurity, NICU stay, neonatal complications, or known genetic conditions?
5. What is the child's language exposure (monolingual, bilingual, primary language at home)?
6. Has the child previously received Early Intervention or developmental therapy services?
7. Were prior screening scores in any concerning zone?

Required Documents

• Previous well-child visit notes with developmental documentation
• Prior ASQ-3 and/or ASQ:SE-2 score sheets (if any)
• Early Intervention (EI) evaluations or progress notes (if applicable)
• Subspecialty reports (developmental pediatrics, neurology, audiology) if applicable
• Completed parent questionnaire for current visit

Use corrected age for all milestone assessments in preterm infants until 24 months of age.

Step 1 — Developmental Surveillance (Every Well-Child Visit)

At every visit, document the following per Bright Futures:

Four Surveillance Components

1. Eliciting parental concerns — Ask open-ended: "Do you have any concerns about your child's development, learning, or behavior?" Document verbatim.
2. Maintaining a developmental history — Update milestone achievements since last visit across all domains.
3. Observing the child — Document directly observed behaviors (e.g., "reaches for objects," "speaks in 2-word phrases," "walks independently").
4. Identifying risk factors — prematurity, lead exposure, adverse childhood experiences (ACEs), family history of ASD or intellectual disability.

CDC Milestone Expectations by Age

Any milestone not achieved by the upper age limit triggers formal screening — do not adopt "wait and see."

Step 2 — Formal Developmental Screening (9, 18, 30 Months)

Administer the ASQ-3 at the AAP-recommended ages:

ASQ-3 Administration

• Ensure correct age-interval questionnaire is selected (corrected age for preterm)
• Five domains scored: Communication, Gross Motor, Fine Motor, Problem Solving, Personal-Social
• Each domain yields a raw score compared to cutoff values
• Above cutoff: development appears on schedule
• Monitoring zone (between 1 and 2 SD below mean): provide developmental activities, rescreen at next visit
• Below cutoff (≥ 2 SD below mean): refer for formal evaluation

ASQ:SE-2 (Social-Emotional Screening)

• Administer at 9, 18, 24, and 30 months (or any age with behavioral/emotional concern)
• Scores above cutoff indicate need for further social-emotional evaluation
• Consider concurrent PHQ-2 or Edinburgh for caregiver — maternal depression impacts child development

Step 3 — Autism-Specific Screening (18 and 24 Months)

M-CHAT-R/F Administration

• Administer M-CHAT-R at 18 and 24 months universally
• 20 yes/no items scored; total score 0-20
• Low risk (0-2): no further action unless surveillance concern at future visit
• Medium risk (3-7): administer M-CHAT-R Follow-Up Interview; if still positive, refer
• High risk (8-20): refer directly for diagnostic evaluation; do not wait for Follow-Up

Red Flags for ASD at Any Age

• No babbling by 12 months
• No gesturing (pointing, waving) by 12 months
• No single words by 16 months
• No spontaneous 2-word phrases by 24 months
• Loss of previously acquired language or social skills at any age (regression)

Any regression in language or social skills is an urgent referral — do not rescreen.

Step 4 — Referral Pathway Determination

Based on screening results, determine the appropriate referral:

Early Intervention (birth to age 3)

• Refer when any ASQ-3 domain falls below cutoff or clinical concern is present
• Referral must be made within 7 days; EI has 45 days to complete evaluation by federal mandate (IDEA Part C)
• Document referral date, agency name, and domains of concern

School-Based Services (age 3+)

• Transition from EI to school district evaluation at age 3 (IDEA Part B, Section 619)
• Begin transition planning at 2 years 6 months
• Parents must consent to referral; provide written information about rights

Subspecialty Referral

• Developmental-behavioral pediatrics: global delay, ASD evaluation, complex behavioral presentations
• Pediatric neurology: motor delays with abnormal tone, seizures, regression, microcephaly/macrocephaly
• Audiology: any speech-language delay (hearing must be assessed before attributing to developmental cause)
• Genetics: dysmorphic features, global delay without clear etiology, family history of genetic conditions
• Pediatric ophthalmology: visual fixation concerns, nystagmus, strabismus

Step 5 — Documentation and Follow-Up Plan

Visit Documentation Must Include

• Corrected age (if applicable) and chronological age
• Parental concerns (quoted verbatim if possible)
• Milestones achieved and not yet achieved, organized by domain
• Screening tool administered, version, date, and scores per domain
• Risk zone classification for each domain (on schedule / monitoring / referral)
• Referrals placed with dates and agencies
• Anticipatory guidance provided (age-appropriate developmental activities)
• Next screening schedule date

Follow-Up Timeline

Checkpoint B — Tracking Review

Before finalizing the developmental milestone report:

• Corrected age calculated and applied for preterm infants < 24 months
• Parental concerns documented verbatim
• Surveillance documented across all five developmental domains
• Appropriate screening tool administered per age schedule (ASQ-3 at 9, 18, 30 mo)
• M-CHAT-R/F administered at 18 and 24 months
• All domain scores recorded with risk zone classification
• Referrals placed for all below-cutoff domains with dates and agency
• EI transition planning documented if approaching age 3
• Anticipatory guidance provided and documented
• Follow-up timeline explicitly stated

Quality Audit

Guidelines

• Follow AAP Bright Futures 4th Edition for developmental surveillance schedule and content
• Use ASQ-3 (Ages and Stages Questionnaire, 3rd Edition) as the primary screening tool per AAP
• Use M-CHAT-R/F per Robins et al. for universal autism screening at 18 and 24 months
• Apply corrected age for preterm infants per AAP guidance (correct until 24 months chronological)
• Follow IDEA Part C (birth-3) and Part B Section 619 (3-5) for referral obligations
• CDC "Learn the Signs. Act Early." milestone checklists supplement — but do not replace — validated screening tools
• Do not use parental reassurance as a substitute for formal screening when concern exists
• Bilingual children may have distributed vocabulary across languages — total vocabulary across both languages is the relevant metric
• Escalate to attending for any regression, loss of skills, or parental distress about development
• This skill produces documentation for clinical tracking; it does not replace clinical judgment